NCT06545786

Brief Summary

Postoperative neurocognitive disorders (PND) are serious and common complications after surgery, especially in elderly patients. These disorders can affect cognitive functions for years, deteriorating quality of life and increasing hospital stays and medical costs. Diagnosing PND is challenging due to their varied manifestations, such as memory and attention problems, and the lack of standardized criteria and biomarkers. One well-studied form of PND is postoperative delirium (POD). According to the ICD-10, POD is an organic cerebral syndrome characterized by disturbances in consciousness, attention, perception, and other cognitive functions. Researchers suggest that POD development involves a combination of predisposing and precipitating factors. Electroencephalography (EEG) has been used in anesthesiology to assess anesthesia depth and intraoperative awareness. Modern EEG analysis methods, like spectral analysis, offer new ways to evaluate patients' neurophysiological states. Studies show that EEG monitoring can predict complications such as intraoperative stroke and delirium, particularly in cardiothoracic and neurosurgical operations. The relationship between EEG patterns and POD is not well understood. Specific EEG patterns may indicate the risk of POD, aiding in the identification of risk factors and prevention methods. This could help anesthesiologists and surgeons optimize their approaches, reducing the risk of cognitive complications.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
265

participants targeted

Target at P75+ for all trials

Timeline
15mo left

Started Sep 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Sep 2024Aug 2027

First Submitted

Initial submission to the registry

August 6, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 9, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 25, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2027

Last Updated

April 8, 2025

Status Verified

November 1, 2024

Enrollment Period

2.9 years

First QC Date

August 6, 2024

Last Update Submit

April 4, 2025

Conditions

Keywords

Non-cardiac surgeryAnesthesiaPostoperative DeliriumSilent StrokeEmergence Delirium

Outcome Measures

Primary Outcomes (3)

  • Prognostic value of mean intraoperative alpha rhythm power for the development of postoperative delirium

    The prognostic value assessment is performed using the area under the ROC curve (AUROC). The value ranges from 0.5 to 1.0. The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.

    Through study completion, an average of 3 year

  • Prognostic value of mean intraoperative alpha rhythm power for the development of early postoperative neurocognitive disorders

    The prognostic value assessment is performed using the area under the ROC curve (AUROC). The value ranges from 0.5 to 1.0. The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.

    Through study completion, an average of 3 year

  • Prognostic value of mean intraoperative alpha rhythm power for the development of intraoperative silent brain infarction

    The prognostic value assessment is performed using the area under the ROC curve (AUROC). The value ranges from 0.5 to 1.0. The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.

    Through study completion, an average of 3 year

Secondary Outcomes (10)

  • Prognostic value of maximum intraoperative alpha rhythm power for the development of postoperative delirium

    Through study completion, an average of 3 year

  • Prognostic value of maximum intraoperative alpha rhythm power for the development of early postoperative neurocognitive disorders

    Through study completion, an average of 3 year

  • Prognostic value of maximum intraoperative alpha rhythm power for the development of silent brain infarction

    Through study completion, an average of 3 year

  • The prognostic capability of the "burst suppression" pattern for predicting the development of silent brain infarction

    Through study completion, an average of 3 year

  • The prognostic capability of the "burst suppression" pattern for predicting the development of postoperative delirium.

    Through study completion, an average of 3 year

  • +5 more secondary outcomes

Other Outcomes (2)

  • Serum level of S100 beta protein

    within 1 hour before surgery, 1 hour after surgery

  • Serum level of Interleukin-6

    within 1 hour before surgery, 1 hour after surgery

Study Arms (1)

Non-cardiac surgery

Patients scheduled for non-cardiac surgery of intermediate to high risk

Device: Intraoperative electroencephalography

Interventions

EEG recording will be performed using the standard 16-electrode configuration according to the international "10-20" system. During the recording, electrode impedances will be maintained at a level not exceeding 5 kilo-ohms.

Non-cardiac surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled for non-cardiac surgery of intermediate to high risk

You may qualify if:

  • Age ≥ 18 years
  • Scheduled non-cardiac surgery of intermediate or high risk
  • General anesthesia using inhalational anesthetics
  • Informed consent from the patient to participate in the study

You may not qualify if:

  • Preoperative MMSE score less than 20 points
  • History of any mental illness
  • Presence of neuromuscular diseases
  • Neurosurgical procedures
  • Inability to undergo preoperative testing for any reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

City clinical hospital named after SS Yudin

Moscow, Moscow Oblast, 115446, Russia

RECRUITING

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Valery Likhvantsev, PhD

    Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Valery Likhvantsev, PhD

CONTACT

Levan Berikashvili, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

August 6, 2024

First Posted

August 9, 2024

Study Start

September 25, 2024

Primary Completion (Estimated)

August 20, 2027

Study Completion (Estimated)

August 20, 2027

Last Updated

April 8, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations